Uncategorized

AI data becomes sticking point in biopharma dealmaking

Published

on

As drug hunting gets more complex, where and how data is generated in partnerships between Big Pharmas and AI biotechs is becoming a headache for dealmakers.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version